Attendees from a wide range of backgrounds · senior staff from manufacturers and government, patient advocates, consultants, academics and students - gain insights into how reimbursement systems across Canada function, how reimbursement is observed from the payers' perspective, and gain a broader understanding of the multiple factors required to successfully manage a market access portfolio.

CAHR events provide insight into the major challenges facing the industry, important trends, and areas of innovation and growth, combining education on the fundamentals of the Cana­dian pharmaceutical reimbursement platform with thought-provoking discussion and productive networking opportunities.

CAHR MARKET ACCESS 101 (MA101) 
Provides an introduction to the various fields of activity involved in market access, from clinical trials to budget impact analysis and government relations. Next  MA101 will be offered - Spring/Summer 2025!

CAHR MARKET ACCESS FORUM
The CAHR Market Access Forum delivers multifaceted insights into current issues, key topics and health care policy of paramount importance to the pharmaceutical industry and its various stakeholders. It provides attendees with context and insight to better understand the issues facing market access professionals.

The new annual CAHR Market Access Forum – which reimagines and replaces Market Access 201* – covers a broad spectrum of provincial and national themes and is intended for those with an existing knowledge of the Canadian pharmaceutical market access environment and the processes and players involved in bringing products to market.

In general, the CAHR Market Access Forum focuses on:

• Provincial and federal health care policy
• Current trends and future direction
• Innovative, specialty and generic products
• Medical technologies
• Patient access to medicines
• Clinicians’ scope of practice changes and the evolution of prescribing

The CMAP program allows you to be recognized as possessing the unique skill set that defines the modern market access professional. Comprehensive and complete, the program encompasses a broad range of subjects of direct relevance to your daily activities.

Upon completion, you will be able to:

• Explain why market access is critical to commercial success.
• Describe the market access players in the public and private payer environments.
• Discuss how review processes, pricing and regulations impact public and private payer environments.
• Find the information necessary to understand public and private submission processes.
• Identify key players in the market access and reimbursement environments.
• Discuss the intricacies of bringing a new drug to market in Canada.
• Identify the key approvals pathways, processes and agencies involved in bringing a new drug to market in Canada
• Leverage a solid foundation in all areas of Patient Support Programs in Canada

*Attendance at CAHR's Market Access 101 and Market Access Forum is required to complete the Certified Market Access Professional (CMAP) certification.

Successful completion of the program qualifies you as a CMAP - Certified Market Access Professional and is verifiable through CAHR.

If you're working towards your CMAP Certification you MUST attend both Market Access 101 and Market Access Forum (formerly Market Access 201).

**Limited number of special discounts available to patient groups and students. Please contact the CAHR office for information.